Hernandez v. Zenlen, Inc.

CourtDistrict Court, S.D. New York
DecidedFebruary 3, 2025
Docket1:24-cv-04846
StatusUnknown

This text of Hernandez v. Zenlen, Inc. (Hernandez v. Zenlen, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hernandez v. Zenlen, Inc., (S.D.N.Y. 2025).

Opinion

Cc OV I N G T O N Covington & Burling LLP The New York Times Building BEIJING BOSTON BRUSSELS DUBAI FRANKFURT 620 Eighth Avenue JOHANNESBURG LONDON LOS ANGELES NEW YORK New York, NY 10018-1405 PALO ALTO SAN FRANCISCO SEOUL SHANGHAI WASHINGTON T +1212 8411000

By CM/ECF January 31, 2025 The Honorable Denise Cote Granted. United States District Court for the 4) Southern District of New York po! (ie 500 Pearl Street, Room 1910 poe a New York, NY 10007 February 3, 2025

Re: Hernandez vy. Zenlen, Inc., No. 1:24-cv-04846-DLC (S.D.N.Y.) Dear Judge Cote: Pursuant to Rule 8(B) of Your Honor’s Individual Rules and Practices, Defendant Zenlen, Inc. (“Zenlen”), respectfully seeks leave to file under seal the redacted a clinical testing report referenced in paragraph 24 of the Plaintiff's Amended Complaint (ECF No. 31) and appended to the Declaration of Andrew Leff as Exhibit A. As required under Rule 8(B), Exhibit A has been contemporaneously filed on ECF under seal and electronically related to this motion. Zenlen submits this letter motion because good cause exists to file under seal Exhibit A, which contains proprietary, commercially sensitive, and highly confidential business information. Disclosure of the highly confidential clinical testing protocols and methodology contained in Exhibit A would harm Zenlen’s business interests and put Zenlen at a competitive disadvantage. See, e.g., Kewazinga Corp. v. Microsoft Corp., 2021 WL 1222122, at *6 (S.D.N.Y. Mar. 31, 2021) (“Examples of commonly sealed documents include those containing ... confidential research and development information[.]”); Jn re Zimmer M/L Taper Hip Prosthesis, 2021 WL 4706199, at *4 (S.D.N.Y. Oct. 8, 2021) (granting motion to seal documents describing “internal testing, test results, and product specifications” as containing “proprietary business information”). Zenlen has produced this information to Plaintiff's counsel pursuant to a signed non-disclosure agreement, whereby Plaintiff has agreed to hold the information as confidential and not disclose it to any third party. To the extent the Court has any concerns about filing Exhibit A under seal, Zenlen respectfully requests an opportunity to provide additional information. Accordingly, Zenlen respectfully requests that the Court grant this letter motion to file Exhibit A under seal.

COVINGTON The Honorable Denise Cote January 31, 2025 Page 2

Respectfully submitted, /s/ Andrew Soukup Andrew Soukup

ce: All counsel of record (via CM/ECF)

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
Hernandez v. Zenlen, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/hernandez-v-zenlen-inc-nysd-2025.